Novo opens its own pharmacy channel with Wegovy at $499 a month
NovoCare Pharmacy sells Wegovy pens straight to people paying cash, at one price for every dose and well under the list price.
Who feels it
-
Patients
Rethink
One flat cash price for all doses, delivered to your home, no insurance needed.
-
Sellers
Rethink
Answers Lilly’s vial channel with pens, not vials.
-
Pharmacies
Adjust
Cash patients who used to fill at local stores may move to mail delivery.
-
Prescribers
Worth knowing
Little change in how you prescribe; the script just goes to a different pharmacy.
-
Payers
Worth knowing
A visible cash price makes it harder to justify high list prices in negotiations.
What launched
NovoCare Pharmacy opened to sell Wegovy directly to patients paying cash. Every dose cost $499 for a month’s supply, delivered to the home.
How it compares
Wegovy’s list price was about $1,349 a month. The new cash price was roughly a third of that, and it came in the familiar pen, not a vial.
Why now
The semaglutide shortage had ended, and compounded copies were being phased out. A lower cash price gave people a branded option at the moment the copies were disappearing.
Who it affects
Mostly people whose insurance does not cover obesity drugs, and the pharmacies and clinics that served them.
Source Novo Nordisk press release, 5 March 2025
Spotted an error? Tell us through the contact form; we follow the corrections policy.
